BIOLOGY AND BIOTECHNOLOGY
Genmab Approves 2026 Board Remuneration - GMAB
Genmab A/S approved a remuneration proposal for 2026, granting 5,300 restricted stock units to board members.
NORTH AMERICAASIA PACIFICEUROPEIMMUNE MODULATING ANTIBODIESGENMABMARISOL PERON